Castleark Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | – | Sell |
-13,245
| Closed | -$2.29M | – | 359 |
|
2020
Q4 | $2.29M | Buy |
+13,245
| New | +$2.29M | 0.09% | 189 |
|
2020
Q2 | – | Sell |
-79,624
| Closed | -$5.36M | – | 370 |
|
2020
Q1 | $5.36M | Sell |
79,624
-1,675
| -2% | -$113K | 0.32% | 90 |
|
2019
Q4 | $6.85M | Sell |
81,299
-1,576
| -2% | -$133K | 0.27% | 123 |
|
2019
Q3 | $6.2M | Buy |
+82,875
| New | +$6.2M | 0.25% | 133 |
|
2019
Q2 | – | Sell |
-88,358
| Closed | -$4.26M | – | 379 |
|
2019
Q1 | $4.26M | Sell |
88,358
-159,155
| -64% | -$7.67M | 0.16% | 167 |
|
2018
Q4 | $8.29M | Sell |
247,513
-106,915
| -30% | -$3.58M | 0.35% | 86 |
|
2018
Q3 | $18.6M | Sell |
354,428
-10,525
| -3% | -$552K | 0.53% | 45 |
|
2018
Q2 | $11.4M | Sell |
364,953
-12,057
| -3% | -$377K | 0.35% | 93 |
|
2018
Q1 | $8.22M | Sell |
377,010
-46,623
| -11% | -$1.02M | 0.26% | 123 |
|
2017
Q4 | $8.56M | Sell |
423,633
-24,825
| -6% | -$501K | 0.26% | 131 |
|
2017
Q3 | $8.9M | Buy |
+448,458
| New | +$8.9M | 0.28% | 129 |
|